yahoo_financeOriginal article
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
Neutral
AI Analysis
Summary
Roivant announced that Genevant Sciences and Arbutus Biopharma have reached a $2.25 billion global settlement with Moderna, representing a resolution of disputes between the parties.
Outcome Details
Global settlement agreement announced
Importance:6/10
Sentiment:
0.00
settlementintellectual propertylitigation resolution
Related Companies
Read the original article
Published by yahoo_finance on March 3, 2026 9:15 PM